News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Nagler David
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/22/2018 |
4
| Nagler David (SVP, HR & Corp. Affairs) has filed a Form 4 on Audentes Therapeutics, Inc.|
Txns:
| Sold 4,700 shares
@ $45.2457, valued at
$212.7k
Sold 300 shares
@ $46.0201, valued at
$13.8k
Exercised 5,000 options to buy
@ $2.1852, valued at
$10.9k
|
|
| 11/17/2017 |
4
| Nagler David (SVP, HR & Corp. Affairs) has filed a Form 4 on Audentes Therapeutics, Inc.|
Txns:
| Granted 50,000 options to buy
@ $27.39, valued at
$1.4M
|
|
| 09/29/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities:|
Txns:
| Sold 3,750 shares
@ $30, valued at
$112.5k
Exercised 3,750 options to buy
@ $2.1852, valued at
$8.2k
|
|
| 09/19/2017 |
4
| Nagler David (SVP, HR & Corp. Affairs) has filed a Form 4 on Audentes Therapeutics, Inc.|
Txns:
| Sold 3,750 shares
@ $25, valued at
$93.8k
Exercised 3,750 options to buy
@ $2.1852, valued at
$8.2k
|
|
| 01/27/2017 |
4
| Nagler David (SVP, HR & Corp. Affairs) has filed a Form 4 on Audentes Therapeutics, Inc. |
| 03/02/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/20/2009 |
4
| Form 4 -- Statement of changes in beneficial ownership of securities |
|
|